Cargando…
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598192/ https://www.ncbi.nlm.nih.gov/pubmed/34189562 http://dx.doi.org/10.1093/asj/sjab230 |
| _version_ | 1784600764044279808 |
|---|---|
| author | Lorenc, Z Paul Adelglass, Jeffrey M Avelar, Rui L Baumann, Leslie Beer, Kenneth R Cohen, Joel L Cox, Sue Ellen Dayan, Steven H Dover, Jeffrey S Downie, Jeanine B Draelos, Zoe Diana Goldman, Mitchel P Gross, John E Joseph, John H Kaufman-Janette, Joely Moy, Ronald L Nestor, Mark Schlessinger, Joel Smith, Stacy R Weiss, Robert A |
| author_facet | Lorenc, Z Paul Adelglass, Jeffrey M Avelar, Rui L Baumann, Leslie Beer, Kenneth R Cohen, Joel L Cox, Sue Ellen Dayan, Steven H Dover, Jeffrey S Downie, Jeanine B Draelos, Zoe Diana Goldman, Mitchel P Gross, John E Joseph, John H Kaufman-Janette, Joely Moy, Ronald L Nestor, Mark Schlessinger, Joel Smith, Stacy R Weiss, Robert A |
| author_sort | Lorenc, Z Paul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8598192 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85981922021-11-18 Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients Lorenc, Z Paul Adelglass, Jeffrey M Avelar, Rui L Baumann, Leslie Beer, Kenneth R Cohen, Joel L Cox, Sue Ellen Dayan, Steven H Dover, Jeffrey S Downie, Jeanine B Draelos, Zoe Diana Goldman, Mitchel P Gross, John E Joseph, John H Kaufman-Janette, Joely Moy, Ronald L Nestor, Mark Schlessinger, Joel Smith, Stacy R Weiss, Robert A Aesthet Surg J Corrigenda Oxford University Press 2021-06-30 /pmc/articles/PMC8598192/ /pubmed/34189562 http://dx.doi.org/10.1093/asj/sjab230 Text en © 2021 The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigenda Lorenc, Z Paul Adelglass, Jeffrey M Avelar, Rui L Baumann, Leslie Beer, Kenneth R Cohen, Joel L Cox, Sue Ellen Dayan, Steven H Dover, Jeffrey S Downie, Jeanine B Draelos, Zoe Diana Goldman, Mitchel P Gross, John E Joseph, John H Kaufman-Janette, Joely Moy, Ronald L Nestor, Mark Schlessinger, Joel Smith, Stacy R Weiss, Robert A Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title | Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_full | Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_fullStr | Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_full_unstemmed | Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_short | Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients |
| title_sort | corrigendum to: the second of two one-year, multicenter, open-label, repeat-dose, phase ii safety studies of prabotulinumtoxina for the treatment of moderate to severe glabellar lines in adult patients |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598192/ https://www.ncbi.nlm.nih.gov/pubmed/34189562 http://dx.doi.org/10.1093/asj/sjab230 |
| work_keys_str_mv | AT lorenczpaul corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT adelglassjeffreym corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT avelarruil corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT baumannleslie corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT beerkennethr corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT cohenjoell corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT coxsueellen corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT dayanstevenh corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT doverjeffreys corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT downiejeanineb corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT draeloszoediana corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT goldmanmitchelp corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT grossjohne corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT josephjohnh corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT kaufmanjanettejoely corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT moyronaldl corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT nestormark corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT schlessingerjoel corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT smithstacyr corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients AT weissroberta corrigendumtothesecondoftwooneyearmulticenteropenlabelrepeatdosephaseiisafetystudiesofprabotulinumtoxinaforthetreatmentofmoderatetosevereglabellarlinesinadultpatients |